These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 855909)

  • 1. [On the inhibition of cholinesterases by pancuronium (author's transl)].
    Schuh FT
    Anaesthesist; 1977 Mar; 26(3):125-9. PubMed ID: 855909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the molecular mechanism of action of galanthamine, an antagonist of nondepolarizing muscle relaxants (author's transl)].
    Schuh FT
    Anaesthesist; 1976 Sep; 25(9):444-8. PubMed ID: 135519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human plasma cholinesterase and erythrocyte acetylcholinesterase by nondepolarizing neuromuscular blocking agents.
    Kato M; Hashimoto Y; Horinouchi T; Ando T; Ito J; Yamanaka H
    J Anesth; 2000 Jan; 14(1):30-4. PubMed ID: 14564607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the cholinesterase inhibiting properties of two pyrrolidine derivatives.
    Schuh FT
    Arzneimittelforschung; 1977; 27(12):2271-3. PubMed ID: 580040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of reversible inhibition of cholinesterases by quaternary diaminoalkyl esters of aromatic dicarboxylic acids].
    Volkova RI; Dmitrieva EN
    Biokhimiia; 1976 Mar; 41(3):443-51. PubMed ID: 1276277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases.
    Foldes FF; Deery A
    Br J Anaesth; 1983; 55 Suppl 1():31S-34S. PubMed ID: 6134540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor.
    Bartolini M; Cavrini V; Andrisano V
    J Chromatogr A; 2007 Mar; 1144(1):102-10. PubMed ID: 17134713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
    Berman HA; Leonard K
    Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of plasma cholinesterase by pancuronium and vecuronium].
    Popović L; Kunec-Vajić E
    Lijec Vjesn; 1990; 112(5-6):142-3. PubMed ID: 1978211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of cholinesterases by pancuronium.
    Stovner J; Oftedal N; Holmboe J
    Br J Anaesth; 1975 Sep; 47(9):949-54. PubMed ID: 1191483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase.
    Kamal MA
    Anticancer Res; 1996; 16(6B):3725-30. PubMed ID: 9042248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
    al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
    Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibitory effect of aflatoxin B1 on acetylcholinesterase activity in mouse brain.
    Cometa MF; Lorenzini P; Fortuna S; Volpe MT; Meneguz A; Palmery M
    Toxicology; 2005 Jan; 206(1):125-35. PubMed ID: 15590113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholinesterase inhibition in vitro by huperzine analogs.
    Tang XC; Xu H; Feng J; Zhou TX; Liu JS
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):107-10. PubMed ID: 8010100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
    Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of benzoylcholine on ChE activity in rabbit and rat brain and erythrocytes (author's transl)].
    Murai M
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):115-22. PubMed ID: 7016691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.